Atlas Trials

Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

Clinical trial NCT04344054 · COMPLETED

Trial details

NCT number
NCT04344054
Sponsor
PATH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rotavirus Vaccine
Start date
2021-02-22
Primary completion
2022-09-06
Enrollment
850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.